Search

Your search keyword '"Matej Orešič"' showing total 434 results

Search Constraints

Start Over You searched for: Author "Matej Orešič" Remove constraint Author: "Matej Orešič"
434 results on '"Matej Orešič"'

Search Results

101. The Role of Omic Technologies in the Study of the Human Gut Microbiome

102. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

103. Correction to 'Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling'

104. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

105. The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue

106. Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis

107. Association Between Circulating Lipids and Future Weight Gain in Individuals With an At-Risk Mental State and in First-Episode Psychosis

108. Publisher Correction: Building an international consortium for tracking coronavirus health status

109. Perfluoroalkyl Substances are increased in patients with Late-Onset Ulcerative colitis and induce Intestinal Barrier defects ex vivo in Murine Intestinal tissue

110. Building an international consortium for tracking coronavirus health status

111. Deep learning meets metabolomics: a methodological perspective

112. MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans

113. Double Derivatization Strategy for High-Sensitivity and High-Coverage Localization of Double Bonds in Free Fatty Acids by Mass Spectrometry

114. Building an International Consortium for Tracking Coronavirus Health Status

115. Circulating lipids associate with future weight gain in individuals with an at-risk mental state and in first-episode psychosis

116. Dysregulated lipid metabolism precedes onset of psychosis in people at clinical high risk

117. Early-life exposure to perfluorinated alkyl substances modulates lipid metabolism in progression to celiac disease

118. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines

119. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response

120. Quantitative genome-scale metabolic modeling of human CD4+ T cell differentiation reveals subset-specific regulation of glycosphingolipid pathways

121. Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD

122. Sphingolipids and glycerophospholipids - The 'ying and yang' of lipotoxicity in metabolic diseases

123. Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma

125. P018 Per- and polyfluoroalkyl substances (PFAS) are significantly increased in patients with late-onset of ulcerative colitis

126. Metabolomics Analytics Workflow for Epidemiological Research

127. Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences:Evidence From the Avon Longitudinal Study of Parents and Children

128. Targeted Clinical Metabolomics Platform for the Stratification of Diabetic Patients

129. Metabolic Alterations in Human Peripheral Blood Mononuclear Cells Associate with Progression to Islet Autoimmunity and Type 1 Diabetes

130. The Consortium of Metabolomics Studies (COMETS):Metabolomics in 47 Prospective Cohort Studies

131. Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes

132. Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids

133. Cord-Blood Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes

134. Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview

135. Molecular lipids in prediction of psychosis and the associated cardiometabolic co-morbidities

136. Systems biology approaches to study lipidomes in health and disease

137. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

138. Bioanalytical techniques in nontargeted clinical lipidomics

139. Longitudinal plasma metabolic profiles, infant feeding, and islet autoimmunity in the MIDIA study

140. Human serum metabolites associate with severity and patient outcomes in traumatic brain injury

141. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI)

142. Modeling strategies to study metabolic pathways in progression to type 1 diabetes – Challenges and opportunities

143. A healthy Nordic diet alters the plasma lipidomic profile in adults with features of metabolic syndrome in a multicenter randomized dietary intervention

145. A computational framework to integrate high-throughput '-omics' datasets for the identification of potential mechanistic links

146. Effect of perfluorooctanesulfonic acid (PFOS) on the liver lipid metabolism of the developing chicken embryo

147. Persistent alterations in plasma lipid profiles prior to introduction of gluten in the diet associate with progression to celiac disease

148. Serum Metabolites Associated with Computed Tomography Findings after Traumatic Brain Injury

149. Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes – Type 1 Diabetes Prediction and Prevention Study (DIPP)

150. Platform for systems medicine research and diagnostic applications in psychotic disorders - The METSY project

Catalog

Books, media, physical & digital resources